Patents by Inventor Alexandre Akoulitchev

Alexandre Akoulitchev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240229135
    Abstract: A process for analysing chromosome interactions relating to immunotherapy of cancer.
    Type: Application
    Filed: March 3, 2022
    Publication date: July 11, 2024
    Applicant: Oxford BioDynamics PLC
    Inventors: Aroul Selvam RAMADASS, Ewan HUNTER, Alexandre AKOULITCHEV
  • Patent number: 12006547
    Abstract: A process for analysing chromosome regions and interactions relating to ALS and Huntington's disease.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: June 11, 2024
    Assignee: Oxford BioDynamics PLC
    Inventors: Alexandre Akoulitchev, Aroul Selvam Ramadass, Ewan Hunter, Matthew Salter
  • Publication number: 20240132959
    Abstract: A process for analysing chromosome interactions relating to immunotherapy of cancer.
    Type: Application
    Filed: March 3, 2022
    Publication date: April 25, 2024
    Applicant: Oxford BioDynamics PLC
    Inventors: Aroul Selvam RAMADASS, Ewan HUNTER, Alexandre AKOULITCHEV
  • Publication number: 20240068032
    Abstract: A process for analysing chromosome interactions relating to muscular atrophy.
    Type: Application
    Filed: October 11, 2021
    Publication date: February 29, 2024
    Applicant: OXFORD BIODYNAMICS PLC
    Inventors: Aroul Selvam RAMADASS, Ewan HUNTER, Alexandre AKOULITCHEV
  • Patent number: 11840737
    Abstract: A process for analysing chromosome regions and interactions relating to immunoresponsiveness.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: December 12, 2023
    Assignee: OXFORD BIODYNAMICS PLC
    Inventors: Alexandre Akoulitchev, Aroul Selvam Ramadass, Ewan Hunter
  • Patent number: 11802305
    Abstract: A process for analysing epigenetically active regions of the genome.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: October 31, 2023
    Assignee: Oxford Biodynamics PLC
    Inventors: Alexandre Akoulitchev, Ewan Hunter, Aroul Ramadass
  • Patent number: 11795496
    Abstract: A method of determining responsiveness to therapy for rheumatoid arthritis.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: October 24, 2023
    Assignee: Oxford Biodynamics PLC
    Inventors: Aroul Ramadass, Ewan Hunter, Alexandre Akoulitchev
  • Patent number: 11746378
    Abstract: A process for analysing chromosome regions and interactions relating to breast cancer.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: September 5, 2023
    Assignee: OXFORD BIODYNAMICS PLC
    Inventors: Ewan Hunter, Howard Womersley, Aroul Ramadass, Alexandre Akoulitchev
  • Publication number: 20230193390
    Abstract: A process for analysing chromosome interactions relating to fibrosis.
    Type: Application
    Filed: June 2, 2021
    Publication date: June 22, 2023
    Applicant: OXFORD BIODYNAMICS PLC
    Inventors: Aroul Selvam Ramadass, Ewan Hunter, Alexandre Akoulitchev
  • Publication number: 20230082230
    Abstract: The invention provides a method of determining the epigenetic chromosome interactions which are relevant to a prognostic companion epigenetic test for cancer.
    Type: Application
    Filed: October 28, 2022
    Publication date: March 16, 2023
    Applicant: Oxford BioDynamics, PLC
    Inventors: Francis Hector Grand, Aroul Selvam Ramadass, Alexandre Akoulitchev, Ewan Hunter
  • Publication number: 20230049379
    Abstract: A process for analysing chromosome regions and interactions relating to prognosis of prostate cancer or DLBCL.
    Type: Application
    Filed: May 6, 2020
    Publication date: February 16, 2023
    Applicant: Oxford BioDynamics PLC
    Inventors: Ewan Hunter, Aroul Ramadass, Alexandre Akoulitchev
  • Patent number: 11560597
    Abstract: The invention provides a method of determining the epigenetic chromosome interactions which are relevant to a prognostic companion epigenetic test for cancer.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: January 24, 2023
    Assignee: Oxford BioDynamics, PLC
    Inventors: Francis Hector Grand, Aroul Selvam Ramadass, Alexandre Akoulitchev, Ewan Hunter
  • Patent number: 11535893
    Abstract: The invention provides a method of determining the epigenetic chromosome interactions which are relevant to an epigenetic test for a neurodegenerative condition.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: December 27, 2022
    Assignee: Oxford BioDynamics PLC
    Inventors: Aroul Selvam Ramadass, Ewan Hunter, Alexandre Akoulitchev
  • Publication number: 20220333199
    Abstract: A process for analysing chromosome regions and interactions relating to prognosis of Autism Spectrum Disorder.
    Type: Application
    Filed: September 10, 2020
    Publication date: October 20, 2022
    Applicant: OXFORD BIODYNAMICS PLC
    Inventors: Aroul Selvam RAMADASS, Ewan HUNTER, Alexandre AKOULITCHEV
  • Publication number: 20220282328
    Abstract: A process for analysing chromosome regions and interactions relating to physical performance.
    Type: Application
    Filed: October 21, 2019
    Publication date: September 8, 2022
    Applicant: Oxford BioDynamics PLC
    Inventors: Ewan HUNTER, Aroul RAMADASS, Alexandre AKOULITCHEV
  • Patent number: 11434522
    Abstract: A method of determining the epigenetic chromosome interactions which are relevant to a companion diagnostic.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: September 6, 2022
    Assignee: Oxford Biodynamics PLC
    Inventors: Ewan Hunter, Aroul Ramadass, Alexandre Akoulitchev
  • Patent number: 11384396
    Abstract: Method of detection or diagnosis of abnormal gene expression in an individual comprising determining in a sample from the individual the presence or absence of a chromosome structure in which two separate regions of the gene have been brought into close proximity, to thereby detect or diagnose whether the individual has abnormal gene expression.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: July 12, 2022
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Alexandre Akoulitchev, Aroul Selvam Ramadass, Leonid Leonidovich Nikitenko
  • Publication number: 20210230702
    Abstract: A process for analysing chromosome regions and interactions relating to immunoresponsiveness.
    Type: Application
    Filed: November 2, 2018
    Publication date: July 29, 2021
    Inventors: Alexandre AKOULITCHEV, Aroul Selvam RAMADASS, Ewan HUNTER
  • Publication number: 20210220420
    Abstract: Compositions comprising a nutritionally or pharmaceutically effective dosage of an extract of Salvia officinalis and an acceptable carrier are provided. The compositions show particular potential in the treatment of age-related pathologies in humans or animals. The extracts are obtained from varieties and cultivars of Salvia officinalis that possess a unique chemical fingerprint that includes unusually low thujone content in the leaf. When tested in C. elegans screening assays compositions that comprise the extract elicit an increase in mean chronological lifespan (CLS) in the C. elegans population of at least 10%.
    Type: Application
    Filed: January 27, 2017
    Publication date: July 22, 2021
    Applicant: SIBELIUS LIMITED
    Inventors: Peter Leyland, Alexandre Akoulitchev, Antoine Verslype, Stephen Caiger
  • Publication number: 20200407790
    Abstract: A process for analysing chromosome regions and interactions relating to ALS and Huntington's disease.
    Type: Application
    Filed: October 1, 2018
    Publication date: December 31, 2020
    Inventors: Alexandre AKOULITCHEV, Aroul Selvam RAMADASS, Ewan HUNTER, Matthew SALTER